PCV38 BOSENTAN IS A COST-EFFECTIVE TREATMENT FOR UNITED KINGDOM PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION OF WHO CLASS III
Abstract
Authors
MD Stevenson FC MacDonald J Langley RL Akehurst
MD Stevenson FC MacDonald J Langley RL Akehurst
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now